Literature DB >> 12021328

Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors.

Minoru Tobiume1, Mikako Takahoko, Takeshi Yamada, Masashi Tatsumi, Aikichi Iwamoto, Michiyuki Matsuda.   

Abstract

It has been reported that patients infected with nef-defective human immunodeficiency virus type 1 (HIV-1) do not progress to AIDS; however, mutations that abrogate Nef expression are not common in long-term nonprogressors (LTNPs). We postulated that Nef function might be impaired in LTNPs, irrespective of the presence or absence of detectable amino acid sequence anomalies. To challenge this hypothesis we compared in vitro function of nef alleles that were derived from three groups of Japanese patients: LTNPs, progressors, and asymptomatic carriers (ACs). The patient-derived nef alleles were subcloned into a nef-defective infectious HIV-1 molecular clone and an expression vector. We first examined Nef-dependent enhancement of infection in a single-round infectivity assay by the use of MAGNEF cells, in which Nef is required more strictly for the infection than in the parent MAGI cells. All nef alleles from LTNPs showed reduced enhancement in the infectivity of nef-defective HIV-1 mutants compared to the nef alleles of progressors or ACs. Second, we found that nef alleles from LTNPs were less efficient in CD4 downregulation than those of progressors or ACs. Third, all nef alleles from LTNPs, progressors, and ACs reduced the cell surface expression of major histocompatibility complex class I to a similar level. Last, there was no correlation between Hck-binding activity of Nef and clinical grouping. In conclusion, we detected inefficient enhancement of HIV-1 infectivity and CD4 downregulation by HIV-1 nef alleles of LTNPs. It awaits further study to conclude that these characteristics of nef alleles are the cause or the consequence of the long-term nonprogression after HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021328      PMCID: PMC136235          DOI: 10.1128/jvi.76.12.5959-5965.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

3.  Generation and characterization of the human immunodeficiency virus type 1 mutants.

Authors:  A Adachi; N Ono; H Sakai; K Ogawa; R Shibata; T Kiyomasu; H Masuike; S Ueda
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

Authors:  M Y Chowers; C A Spina; T J Kwoh; N J Fitch; D D Richman; J C Guatelli
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  Requirement of nef for HIV-1 infectivity is biased by the expression levels of Env in the virus-producing cells and CD4 in the target cells.

Authors:  M Tobiume; K Tokunaga; E Kiyokawa; M Takahoko; N Mochizuki; M Tatsumi; M Matsuda
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

7.  Two species of human CRK cDNA encode proteins with distinct biological activities.

Authors:  M Matsuda; S Tanaka; S Nagata; A Kojima; T Kurata; M Shibuya
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

8.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.

Authors:  A Muñoz; M C Wang; S Bass; J M Taylor; L A Kingsley; J S Chmiel; B F Polk
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

9.  Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.

Authors:  J Learmont; B Tindall; L Evans; A Cunningham; P Cunningham; J Wells; R Penny; J Kaldor; D A Cooper
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

10.  The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels.

Authors:  H W Sheppard; W Lang; M S Ascher; E Vittinghoff; W Winkelstein
Journal:  AIDS       Date:  1993-09       Impact factor: 4.177

View more
  22 in total

1.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

2.  Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.

Authors:  Andrea Crotti; Francesca Neri; Davide Corti; Silvia Ghezzi; Silvia Heltai; Andreas Baur; Guido Poli; Elena Santagostino; Elisa Vicenzi
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif.

Authors:  Scott H Coleman; Ricardo Madrid; Nanette Van Damme; Richard S Mitchell; Jerome Bouchet; Cecile Servant; Satish Pillai; Serge Benichou; John C Guatelli
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Neural crest regulates myogenesis through the transient activation of NOTCH.

Authors:  Anne C Rios; Olivier Serralbo; David Salgado; Christophe Marcelle
Journal:  Nature       Date:  2011-05-15       Impact factor: 49.962

6.  CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression.

Authors:  Nicoletta Casartelli; Gigliola Di Matteo; Marina Potestà; Paolo Rossi; Margherita Doria
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses.

Authors:  Jan Münch; Devi Rajan; Michael Schindler; Anke Specht; Elke Rücker; Francis J Novembre; Eric Nerrienet; Michaela C Müller-Trutwin; Martine Peeters; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

8.  Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue.

Authors:  Michael Schindler; Devi Rajan; Anke Specht; Carolin Ritter; Kati Pulkkinen; Kalle Saksela; Frank Kirchhoff
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

Review 9.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788

10.  High-level HIV-1 Nef transient expression in Nicotiana benthamiana using the P19 gene silencing suppressor protein of Artichoke Mottled Crinckle Virus.

Authors:  Raffaele Lombardi; Patrizia Circelli; Maria Elena Villani; Giampaolo Buriani; Luca Nardi; Valentina Coppola; Linda Bianco; Eugenio Benvenuto; Marcello Donini; Carla Marusic
Journal:  BMC Biotechnol       Date:  2009-11-20       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.